GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,461,110 | -47.4% | 1,430,878 | -40.4% | 0.16% | -41.8% |
| Q2 2023 | $4,683,342 | -67.4% | 2,401,714 | -53.5% | 0.28% | -73.1% |
| Q1 2023 | $14,351,327 | -19.4% | 5,162,348 | 0.0% | 1.04% | -6.1% |
| Q4 2022 | $17,810,101 | +32.3% | 5,162,348 | -1.4% | 1.11% | +6.9% |
| Q3 2022 | $13,460,000 | +6.2% | 5,237,348 | 0.0% | 1.04% | -13.4% |
| Q2 2022 | $12,674,000 | -41.3% | 5,237,348 | 0.0% | 1.20% | -35.0% |
| Q1 2022 | $21,578,000 | – | 5,237,348 | – | 1.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |